Quantitative evaluation of HIV prevention programs
Saved in:
Corporate Authors: | , |
---|---|
Other Authors: | , |
Format: | Electronic eBook |
Language: | English |
Published: |
New Haven :
Yale University Press,
c2002.
|
Series: | Yale ISPS series.
|
Subjects: | |
Online Access: | An electronic book accessible through the World Wide Web; click to view |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Machine generated contents note: Part I: Evaluating HIV Prevention Programs: Context and Concepts
- Chapter 1. Overview of HIV Prevention Programs in Developing Countries Michael H. Merson andJulia M. Dayton 13
- Chapter 2. Implications of Economic Evaluations for National HIV Prevention Policy Makers David R. Holtgrave
- and Steven D. Pinkerton 32
- Chapter 3. Statistical Issues in HIV Prevention Ron Brookmeyer 55
- Chapter 4. Epidemiological Issues in the Evaluation of HIV Prevention Programs Nancy S. Padian and Stephen C. Shiboski 79
- Part II: Cost-Effectiveness and Resource Allocation
- Chapter 5. Difficult Choices, Urgent Needs: Optimal Investment in HIV Prevention Programs Margaret L. Brandeau 97 Chapter 6. Methadone Treatment as HIV Prevention: Cost-EffectivenessAnalysis Harold Pollack 118
- Chapter 7. Costs and Benefits of Imperfect HIV Vaccines: Implications for Vaccine Development and Use Douglas K Owens, Donna M. Edwards, and Ross D. Shachter 143
- Part III: Case Studies
- Chapter 8. Harm Reduction in Rome: A Model-Based Evaluation of Its Impact on the HIV-1 Epidemic MassimoArca, Teresa Spadea, Giulia Cesaroni, Marina Davoli, Annette D. Verster, and Carlo A. Perucci 175
- Chapter 9. Evaluating Israel's Ethiopian Blood Ban EdwardH. Kaplan 189
- Chapter 10. Feeding Strategies for Children of HIV-Infected Mothers: Modeling the Trade-Off Between HIV Infection and Non-HIV Mortality James G. Kahn, ElliotMarseille, and Joseph Saba 202
- Part IV: New Methods for New Problems
- Chapter 11. Design of HIVTrials for Estimating External Effects Tomas Philipson 223
- Chapter 12. Estimation of Vaccine Efficacy for Prophylactic HIV Vaccines Ira M Longini, Jr., Michael G. Hudgens, and M. Elizabeth Halloran 241
- Chapter 13. Health Policy Modeling: Epidemic Control, HIVVaccines, and
- Risky Behavior Sally Blower, Katia Koelle,and John Mills 260
- Chapter 14. Development and Validation of a Serologic Testing Algorithm for Recent HIV Seroconversion GlenA. Satten,
- Robert S. Janssen, Susan Stramer, and Michael P Busch 290
- Chapter 15. Issues in Quantitative Evaluation of Epidemiologic Evidence for Temporal Variability of HIV Infectivity Stephen C. Shiboski and Nancy S.
- Padian 305.